Welcome to the Association for Cell & Gene Therapies
Your Home for CGT Education and News
Become a Member Today
An estimated 350,000 patients
will be treated with 30 to 60 cell and gene therapy
products by 2030.
The Association for Cell and Gene Therapy (CGT) Solutions promotes education to all stakeholders to expand knowledge and best practices for the advancement of patient access and affordability.
The Benefits of Joining the Association for CGT Solutions
Access to the latest industry updates, expert insights, and practical resources to
understand the financial,
clinical, and operational best practices for managing cell
and gene therapies.
Cell & Gene Therapy 101
Financial Implications of CGTs
Disease and Therapy Profiles
Patient Support Resources
Insights from Association
Staff & Collaborators
The Latest Updates on FDA Approvals
Reinsurance Coverage Overview
These potentially life-saving therapies come with multi-million-dollar price tags
attached, and the costs
are going nowhere but up. It’s time to fill the holes in your coverage with reinsurance protection available exclusively to ACGTS members.
Highly customizable first-dollar coverage solution for CGTs backed by A-rated carriers
Member access to quality care at top facilities
Data insights that capture essential quality measures
Financial predictability and laser protection
Implement at any time
CGT Conferences & Events
Association memberships are available to eligible employers.